Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial
Lei Fan(Fudan University Shanghai Cancer Center), Zhonghua Wang(Fudan University Shanghai Cancer Center), Linxiaoxi Ma(Fudan University Shanghai Cancer Center), Song‐Yang Wu(Fudan University Shanghai Cancer Center), Jiong Wu(Fudan University Shanghai Cancer Center), Ke‐Da Yu(Fudan University Shanghai Cancer Center), Xin-Yi Sui(Fudan University Shanghai Cancer Center), Ying Xu(Fudan University Shanghai Cancer Center), Xiyu Liu(Fudan University Shanghai Cancer Center), Li Chen(Fudan University Shanghai Cancer Center), Wenjuan Zhang(Fudan University Shanghai Cancer Center), Xi Jin(Fudan University Shanghai Cancer Center), Qin Xiao(Fudan University Shanghai Cancer Center), Ruohong Shui(Fudan University Shanghai Cancer Center), Yi Xiao(Fudan University Shanghai Cancer Center), Han Wang(Fudan University Shanghai Cancer Center), Yun‐Song Yang(Fudan University Shanghai Cancer Center), Xiaoyan Huang(Fudan University Shanghai Cancer Center), A‐Yong Cao(Fudan University Shanghai Cancer Center), Junjie Li(Fudan University Shanghai Cancer Center), Gen‐Hong Di(Fudan University Shanghai Cancer Center), Guang‐Yu Liu(Fudan University Shanghai Cancer Center), Wen-Tao Yang(Fudan University Shanghai Cancer Center), Xin Hu(Fudan University Shanghai Cancer Center), Yan Xia(Jiangsu Hengrui Medicine (China)), Qian-Nan Liang(Jiangsu Hengrui Medicine (China)), Yi‐Zhou Jiang(Fudan University Shanghai Cancer Center), Zhi‐Ming Shao(Fudan University Shanghai Cancer Center)
Cited by 62
Abstract
Related Papers
No related papers found
Powered by citation graph analysis